Eltrombopag can overcome the anti-megakaryopoietic effects of lenalidomide without increasing proliferation of the malignant myelodysplastic syndrome/acute myelogenous leukemia clone

Roni Tamari, Carolina Schinke, Tushar Bhagat, Michael Roth, Ira Braunschweig, Britta Will, Ulrich Steidl, Amit Verma

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Eltrombopag can overcome the anti-megakaryopoietic effects of lenalidomide without increasing proliferation of the malignant myelodysplastic syndrome/acute myelogenous leukemia clone'. Together they form a unique fingerprint.

Medicine & Life Sciences